##fileformat=VCFv4.2
##fileDate=2022-09-07
##reference=GRCh38
##INFO=<ID=assays,Number=.,Type=String,Description="All types of assays (e. g. functional or splicing) which were submitted to HerediVar. Assays are separated by "&" symbols. Format:date|assay_type|score.">
##INFO=<ID=brca_exchange_clinical_significance_20220222,Number=.,Type=String,Description="Variant pathogenicity as displayed in the Summary view version: 54, version date: 2022-02-22">
##INFO=<ID=cadd_scaled_20200411,Number=.,Type=String,Description="The scaled CADD scores: PHRED-like (-10*log10(rank/total)) scaled C-score ranking a variant relative to all possible substitutions of the human genome (8.6x10^9). These scores range from 1 to 99. A cutoff for deleteriousness can be set to 10-15, but the choice remains arbitrary. version: v1.6, version date: 2020-04-11">
##INFO=<ID=clinvar_submissions,Number=.,Type=String,Description="An & separated list of clinvar submissions. Format:interpretation|last_evaluated|review_status|submission_condition|submitter|comment">
##INFO=<ID=clinvar_summary,Number=.,Type=String,Description="summary of the clinvar submissions">
##INFO=<ID=consequences,Number=.,Type=String,Description="An & separated list of variant consequences from vep. Format:Transcript|hgvsc|hgvsp,consequence|impact|exonnr|intronnr|genesymbol|proteindomain|isgencodebasic|ismaneselect|ismaneplusclinical|isensemblcanonical">
##INFO=<ID=external_ids,Number=.,Type=String,Description="All external variant ids recorded in HerediVar. Entries are separated by & symbols. Format:source|id.">
##INFO=<ID=gnomad_ac_20211022,Number=.,Type=String,Description="gnomAD alternate allele count for samples version: v3.1.2, version date: 2021-10-22">
##INFO=<ID=gnomad_af_20211022,Number=.,Type=String,Description="gnomAD frequency of alternate allele in samples version: v3.1.2, version date: 2021-10-22">
##INFO=<ID=gnomad_het_20211022,Number=.,Type=String,Description="gnomAD number of heterozygous individuals in samples version: v3.1.2, version date: 2021-10-22">
##INFO=<ID=gnomad_hom_20211022,Number=.,Type=String,Description="gnomAD number of homozygous individuals in samples version: v3.1.2, version date: 2021-10-22">
##INFO=<ID=gnomad_popmax_20211022,Number=.,Type=String,Description="gnomAD population with maximum allele frequency (AF) version: v3.1.2, version date: 2021-10-22">
##INFO=<ID=gnomad_popmax_AF_20211022,Number=.,Type=String,Description="The allele frequency of the "popmax" population version: v3.1.2, version date: 2021-10-22">
##INFO=<ID=hexplorer_20220630,Number=.,Type=String,Description="The HEXplorer delta score (HZEI mutant - HZEI wildtype). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO=<ID=hexplorer_mut_20220630,Number=.,Type=String,Description="The HEXplorer score for the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO=<ID=hexplorer_rev_20220630,Number=.,Type=String,Description="The HEXplorer delta score for the reverse complement of the original sequence (HZEI mutant rev - HZEI wildtype rev). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO=<ID=hexplorer_rev_mut_20220630,Number=.,Type=String,Description="The HEXplorer score for the reverse complement of the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO=<ID=hexplorer_rev_wt_20220630,Number=.,Type=String,Description="The HEXplorer score for the reverse complement of the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO=<ID=hexplorer_wt_20220630,Number=.,Type=String,Description="The HEXplorer score for the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO=<ID=phylop_100way_20131201,Number=.,Type=String,Description="PhyloP 100 vertebrates (100-way) conservation scores. These scores measure evolutionary conservation at individual alignment sites. Interpretations of the scores are compared to the evolution that is expected under neutral drift. Positive scores: Measure conservation, which is slower evolution than expected, at sites that are predicted to be conserved. Negative scores: Measure acceleration, which is faster evolution than expected, at sites that are predicted to be fast-evolving.  version: -, version date: 2013-12-01">
##INFO=<ID=rsid_20210616,Number=.,Type=String,Description="The rs-number of a variant from dbSNP (version summary: https://www.ncbi.nlm.nih.gov/projects/SNP/snp_summary.cgi) version: 155, version date: 2021-06-16">
##INFO=<ID=spliceai_details_20210907,Number=.,Type=String,Description="Details about the SpliceAI predictions: These include delta scores (DS) and delta positions (DP) for acceptor gain (AG), acceptor loss (AL), donor gain (DG), and donor loss (DL). Format: GENE|DS_AG|DS_AL|DS_DG|DS_DL|DP_AG|DP_AL|DP_DG|DP_DL version: v1.3.1, version date: 2021-09-07">
##INFO=<ID=spliceai_max_delta_20210907,Number=.,Type=String,Description="Max of delta scores for acceptor gain, acceptor loss, donor gain and donor loss. A value of 0.5 or more can be assumed to have an impact on splicing. version: v1.3.1, version date: 2021-09-07">
##INFO=<ID=task_force_protein_domain_20220601,Number=.,Type=String,Description="The description of the protein domain from a hand-crafted table by the VUS-Task-Force. version: -, version date: 2022-06-01">
##INFO=<ID=task_force_protein_domain_source_20220601,Number=.,Type=String,Description="The source of the task force protein domain. version: -, version date: 2022-06-01">
##INFO=<ID=pubmed,Number=.,Type=String,Description="An & separated list of pubmed ids relevant for this variant.">
##INFO=<ID=consensus_classification,Number=1,Type=Integer,Description="The recent consensus classification by the VUS-task-force. Format: consensus_class|consensus_comment|submission_date|consensus_scheme|consensus_scheme_class|consensus_criteria_string. The consensus criteria string itself is a $ separated list with the Format: criterium_name+criterium_strength+criterium_evidence ">
##INFO=<ID=user_classifications,Number=.,Type=String,Description="Classifications by individual users of HerediVar. Single classifications are separated by & symbols. Format: user_class|user_comment|submission_date|user_scheme|user_scheme_class|user_criteria_string. The user criteria string itself is a $ separated list with the Format: criterium_name+criterium_strength+criterium_evidence ">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
chr13	32314943	52	A	G	.	.	rsid_20210616=7988901;phylop_100way_20131201=-0.021;cadd_scaled_20200411=7.930;spliceai_details_20210907=ZAR1L%7C0.00%7C0.00%7C0.02%7C0.00%7C31%7C-39%7C-44%7C32;spliceai_max_delta_20210907=0.02;gnomad_ac_20211022=5753;gnomad_af_20211022=0.0378129;gnomad_hom_20211022=353;gnomad_het_20211022=5047;gnomad_popmax_20211022=afr;brca_exchange_clinical_significance_20220222=Benign_/_Little_Clinical_Significance;task_force_protein_domain_20220601=C-terminal_RAD51_binding_domain_(inkl._NLS1_und_BRC-)_;task_force_protein_domain_source_20220601=BWRL/ENIGMA;hexplorer_20220630=-5.12;hexplorer_mut_20220630=-4.84;hexplorer_wt_20220630=0.28;hexplorer_rev_20220630=4.56;hexplorer_rev_mut_20220630=-1.44;hexplorer_rev_wt_20220630=-6.00;gnomad_popmax_AF_20211022=0.131678;pubmed=9425226&15342711&16333312&25994375;clinvar_summary=reviewed_by_expert_panel:Benign;clinvar_submissions=Benign|2015-01-12|reviewed_by_expert_panel|C2675520:Breast-ovarian_cancer,_familial_2|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|description:_Class_1_not_pathogenic_based_on_frequency_>1%_in_an_outbred_sampleset._Frequency_0.14_(African),_derived_from_1000_genomes_(2012-04-30).;consequences=ENST00000345108|None|None|upstream_gene_variant|modifier|None|None|ZAR1L|1|0|0|0&ENST00000380152|None|None|upstream_gene_variant|modifier|None|None|BRCA2|1|1|0|1&ENST00000530893|None|None|upstream_gene_variant|modifier|None|None|BRCA2|0|0|0|0&ENST00000533490|c.-390%2B372T>C|None|intron_variant|modifier|None|1|ZAR1L|1|1|0|1&ENST00000544455|None|None|upstream_gene_variant|modifier|None|None|BRCA2|1|0|0|0&ENST00000614259|None|None|upstream_gene_variant|modifier|None|None|BRCA2|0|0|0|0&ENST00000680887|None|None|upstream_gene_variant|modifier|None|None|BRCA2|0|0|0|0&ENSR00000060894|None|None|regulatory_region_variant|modifier|None|None|None|None|None|None|None&ENSM00526233310|None|None|TF_binding_site_variant|modifier|None|None|None|None|None|None|None&ENSM00522614247|None|None|TF_binding_site_variant|modifier|None|None|None|None|None|None|None&NM_000059|None|None|upstream_gene_variant|modifier|None|None|BRCA2|1|1|0|1&NM_001136571|c.-390%2B372T>C|None|intron_variant|modifier|None|1|ZAR1L|1|1|0|1;consensus_classification=5|A_random_test_classification|2022-09-07_03:00:00|acmg_standard|5|ps1+medium_pathogenic+ev1$ps2+strong_pathogenic+ev2$ps1+supporting_pathogenic+ev3;assays=2022-08-08|functional|12345.0&2022-08-09|functional|6565.0&2022-08-09|splicing|3654.0;external_ids=heredicare|11740058&sometest|blimblam2;user_classifications=3|this_is_a_comment_with\tpecial_characters|2022-10-06_06:00:00|acmg_standard|5|ps1+supporting_pathogenic+evidence1$ps2+strong_pathogenic+evidence2$pp1+strong_pathogenic+evidence3
